We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Daffodils to Treat Alzheimer's

By Biotechdaily staff writers
Posted on 29 Aug 2005
A substance found in daffodils, the national flower of Wales, may help treat patients with Alzheimer's disease (AD), the most common form of dementia that is accompanied by loss of memory.

Certain daffodil species, which thrive in the Black Mountains of eastern Wales, produce galanthamine, a drug designed to alleviate loss-of-memory symptoms. The Manufacturing Engineering Center of Cardiff University (Wales, UK;) is helping to develop the agricultural potential of the daffodil as a medicinal plant, along with the Institute of Grassland and Environmental Research at the University of Wales, Aberystwyh (UK).

The center is providing support ranging from harvesting in the field to marketing the pharmaceutical product. This includes assisting with the science of developing crops more than once a year and helping growers to assess when is the best time to harvest the crop.

"Galanthamine has major investment potential,” stated Frank Marsh, marketing director of the Manufacturing Engineering Center. "Furthermore, the potential for Welsh hill farms is huge. The benefits are extensive, not only to Welsh bioscience and the pharmaceutical industry but also to the aging population.”





Related Links:
Cardiff University
Univ. of Wales, Aberystwyh

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000

Latest BioResearch News

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
29 Aug 2005  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
29 Aug 2005  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
29 Aug 2005  |   BioResearch